Brief: Karuna Therapeutics Reports Q3 Loss Of $2.38 Per Share
03/11/2022 10:37
Nov 3 (Reuters) - Karuna Therapeutics Inc KRTX.O :
* KARUNA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES GENERAL BUSINESS UPDATES
* KARUNA THERAPEUTICS INC - $1.2 BILLION IN CASH IS EXPECTED
TO
FUND OPERATIONS THROUGH END OF 2025
* KARUNA THERAPEUTICS INC QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $2.38
Source text for Eikon: ID:nBw5FnBG9a
Further company coverage: KRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)